Clinical trial
Ticagrelol Versus Aspirin in Ischemic Stroke
NCT03884530 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ticagrelol Versus Aspirin in Ischemic Stroke
- Lead sponsor
- Kafrelsheikh University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 1, 2019
- Completion date
- September 30, 2020
- Enrollment
- 169 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute stroke, ischemic stroke